By Dow Jones Business News,
June 20, 2014, 12:38:00 PM EDT
By Sara Sjolin, MarketWatch
LONDON (MarketWatch) -- U.K.'sFTSE 100 index outperformed most other European markets and rose for a fourth straight
day on Friday as drug maker Shire surged more than 15% after rejecting a takeover proposal.
The benchmark index in London gained 0.3% to close at 6,825.20, ending with a 0.7% weekly advance.
Leading the pack, Shire PLC jumped 17% after the pharma firm rejected a 27.2 billion-pound ($46.35 billion) takeover
bid from U.S. rival AbbVie Inc. ( ABBV ), citing a fundamentally undervaluation of the company. AbbVie said discussions
were no longer ongoing and that there could be no certainty that any firm offer would be made.
AstraZeneca PLC (AZN) -- which recently rebuffed an acquisition bid from Pfizer Inc. ( PFE ) -- picked up 0.6%.
Outside the main index in London, shares of TSB Banking Group PLC soared 12% on its first trading day. The move took
Lloyds Banking Group PLC ( LYG ) one step closer to selling off the whole TSB unit as part of a condition of its
government bailout. The lender must divest its remaining shares in TSB by the end of next year.
Lloyds listed 175 million shares in TSB, or 35% of the business, raising GBP455 million and selling a bigger stake
than initially planned. Lloyds shares dropped 0.9%.
More must-reads from MarketWatch:
Feeble growth raises doubt about EU recovery
Yellen green-lights gold bulls
Apple smartwatch production starts next month
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
Copyright (c) 2014 Dow Jones & Company, Inc.